Turning Point Therapeutics Appoints Annette North as Executive Vice President and General Counsel

SAN DIEGO–(BUSINESS WIRE)–Turning Point Therapeutics, Inc., a clinical-stage precision oncology company developing novel drugs that address treatment resistance, announced today the appointment of Annette C. North as executive vice president and general counsel, effective April 15. In this role, Ms. North will also serve as company secretary. “Annette brings a wealth of experience and depth to our growing management team through 25 years serving biotechnology companies from inception through

Click to view original post

Advertise With Us